Biedermann Motech, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$231Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
217clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Moss Vrs Spinal System $23K associated (2023-2025)
- Distal Radius Plating System 2.0 $6,530 associated (2023-2025)
- Proximal Humerus Plating System $5,208 associated (2023-2025)
- Olecranon Plating System $4,946 associated (2023-2025)
- Moss Vrs Mis Spinal System $4,216 associated (2023-2025)
- Moss100 Pedicle Screw System $3,987 associated (2023-2025)
- Distal Humerus Plate $2,970 associated (2023-2025)
- Telix K Interbody System $899 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Aaron Buckland | New York, NY | Orthopaedic Surgery of The Spine | $31,324.34 |
| Surena Namdari | Philadelphia, PA | Orthopaedic Surgery | $22,373.95 |
| Samir Mehta | Philadelphia, PA | Orthopaedic Surgery | $20,598.69 |
| Edward Paxton | Providence, RI | Orthopaedic Surgery | $14,459.95 |
| Isaac Moss | Farmington, CT | Orthopaedic Surgery | $11,870.61 |
| Arun Hariharan | Mangonia Park, FL | Pediatric Orthopaedic Surgery | $10,714.67 |
| Alexander Powers | Kernersville, NC | Neurological Surgery | $7,769.71 |
| Robert Masson | Ocoee, FL | Neurological Surgery | $7,205.86 |
| Michael Rivlin | Bensalem, PA | Hand Surgery | $7,123.18 |
| Jahangir Asghar | Plantation, FL | Orthopaedic Surgery of The Spine | $6,328.87 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.